Veterinary Parasiticides Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Bayer AG, Zoetis Inc., Boehringer Ingelheim, Merck & Co. Inc., Eli Lilly and Company, virology and bacteriology, Ceva Animal Health, Merial Inc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Veterinary Parasiticides Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The veterinary parasiticides market size has grown strongly in recent years. It will grow from $13.86 billion in 2023 to $14.81 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to animal health awareness, livestock production, companion animal ownership, zoonotic diseases.

The veterinary parasiticides market size is expected to see strong growth in the next few years. It will grow to $19.09 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to global food security, emerging zoonotic threats, companion animal care, environmental changes. Major trends in the forecast period include zoonotic disease concerns, flea and tick control innovation, parasiticide safety and environmental concerns, innovative delivery methods.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=2457&type=smp

Market Segmentation:
The main types of veterinary parasiticides are endoparasiticides, ectoparasiticides, and endectocides. Endectocides are medications that are administered directly to hosts to kill endoparasites and ectoparasites, primarily blood-feeding arthropods. The product types include oral liquids, tablets, injectables, sprays, and other products applied on farm animals, and companion animals that are used by R&D facilities, farms, and veterinary clinics.

Major Driver - Zoonotic Pathogens Drive Demand For Veterinary Parasiticides
Animals are increasingly being affected by zoonotic pathogens, which are the leading cause of foodborne diseases worldwide. Zoonotic diseases are infectious diseases caused by bacteria, viruses, and parasites, especially Salmonella and Campylobacter, which can be transmitted directly or indirectly between animals and humans. These diseases get passed through the food chain to humans which is a potential threat and creates a dire need to prevent such diseases among animals. For instance, in December 2022, according to the European Food Safety Authority, an Italy-based independent agency for providing scientific advice on food and feed safety, nutrition, and related issues, in 2021 there were 4,005 foodborne incidents, which is an increase of 29.8% when compared to 2020. The necessity to curb these infections in animals drives the market for veterinary parasiticides.

Competitive Landscape:
Major companies operating in the veterinary parasiticides market include Bayer AG, Zoetis Inc., Boehringer Ingelheim, Merck & Co. Inc., Eli Lilly and Company, virology and bacteriology, Ceva Animal Health, Merial Inc., Perrigo Company, Vetoquinol India Animal Health Pvt Ltd., Intas Pharmaceuticals Ltd., Perrigo Company, Eli Lilly and Company, Dechra Pharmaceuticals plc, Lillidale Ltd., Phibro Animal Health Corporation, Bovian Health Care Pvt. Ltd., Sanofi SA, Novartis AG, Oceanic Pharmachem, IDEXX Laboratories Inc., Covetrus Inc., Norbrook Laboratories Limited, Bimeda Holdings PLC, PetIQ Inc., Heska Corporation, Neogen Corporation, Kyoritsu Seiyaku Corporation, Nexvet Biopharma plc, Kepro Technologies Private Limited, ECO Animal Health Group plc, Bioniche Animal Health Canada Inc., Bioiberica S.A., Laboratorios Hipra S.A., Norbrook Laboratories Limited

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report

Top Trend - Innovative Chewable Tablets Revolutionize Veterinary Parasiticides
Chewable tablets are being used to prevent animals from being affected by ticks, worms, fleas, and others. Treatments with these tablets are easier to administer. The chewable tablets are available in either a beef-flavored tablet or soft chew. For instance, the IVERHART MAX chewable tablets protect dogs from the 4 most common worms: heartworms (infection caused by the bite of an infected mosquito), roundworms, hookworms (affects the intestines), and tapeworms (caused by ingesting an infected flea). Such advances in technology are significantly driving the veterinary parasiticides industry.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Veterinary Parasiticides Market Characteristics
3. Veterinary Parasiticides Market Trends And Strategies
4. Veterinary Parasiticides Market - Macro Economic Scenario
5. Veterinary Parasiticides Market Size And Growth
…..
27. Veterinary Parasiticides Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.